Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.

  • Shabo I
  • Olsson H
  • Sun X
 et al. 
  • 7

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Expression of the macrophage antigen CD163 in breast cancer cells is recently shown to be related to early distant recurrence and shortened survival. In this study, 163 patients with rectal cancer, included in the Swedish rectal cancer trial and followed up for a median of 71 months, were examined for the expression of CD163 in the primary tumors. The cancer cells expressed CD163 in the primary tumors in 23% (n = 32) of the patients. In pretreatment biopsies from 101 patients, 10 had CD163-positive cancers and these patients had earlier local recurrence (p < 0.044) and reduced survival time (p < 0.045) compared with those with CD163-negative tumors. When studying surgical specimens from 61 patients randomized to preoperative irradiation (5 x 5 Gy delivered in 1 week), it was found that 31% were CD163 positive whereas the corresponding figure was only 17% for 78 patients who were nonirradiated (p < 0.044), which tentatively may be consistent with X-rays inducing fusion. In CD163-positive tumors there was a reduced apoptotic activity as measured with the Termina deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling (TUNEL) technique (p = 0.018). There tended also to be an increased proliferation activity measured as an expression of Ki-67 non significant (NS). It is concluded that primary rectal cancers may express CD-163, and this phenotypic macrophage trait is related to early local recurrence, shorter survival time and reduced apoptosis. Furthermore, the expression of CD163 is more common after irradiation.

Author-supplied keywords

  • Aged
  • Antigens
  • Apoptosis
  • Biomarkers
  • CD
  • CD: metabolism
  • Case-Control Studies
  • Cell Proliferation
  • Cell Surface
  • Cell Surface: metabolism
  • Combined Modality Therapy
  • Differentiation
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Local
  • Local: metabolism
  • Local: mortality
  • Local: therapy
  • Macrophages
  • Macrophages: metabolism
  • Macrophages: pathology
  • Male
  • Middle Aged
  • Myelomonocytic
  • Myelomonocytic: metabol
  • Neoplasm Recurrence
  • Neoplasm Staging
  • Preoperative Care
  • Prognosis
  • Radiotherapy Dosage
  • Receptors
  • Rectal Neoplasms
  • Rectal Neoplasms: metabolism
  • Rectal Neoplasms: mortality
  • Rectal Neoplasms: therapy
  • Survival Rate
  • Tissue Array Analysis
  • Tumor
  • Tumor: metabolism

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Ivan Shabo

  • Hans Olsson

  • Xiao-Feng Sun

  • Joar Svanvik

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free